comparemela.com
Home
Live Updates
Mayank Mamtanib Riley - Breaking News
Pages:
3
4
5
6
7
8
9
Latest Breaking News On - Mayank mamtanib riley - Page 2 : comparemela.com
Agenus (AGEN) Q3 2022 Earnings Call Transcript
AGEN earnings call for the period ending September 30, 2022.
United states
Comunidad autonoma de cataluna
Larry norton
Dhan chand
Mayank mamtani
Bree wilky
Matt phipps william blair
Garo armen
David dai
Nico frelick
Todd yancey
Matt phipps
Christine klaskin
Mayank mamtanib riley
Breelyn wilky
Patricia carlos
Agenus (AGEN) Q2 2022 Earnings Call Transcript
AGEN earnings call for the period ending June 30, 2022.
Comunidad autonoma de cataluna
Ethan lovell
Dhan chand
Mayank mamtani
Matt phipps
Dave windley jefferies
Christine klaskin
Mayank mamtanib riley
Matt phipps william blair
Kelly shi
Garo armen
William blair
World congress
External affairs
Chief executive
Scientific director
Arrowhead Pharmaceuticals (ARWR) Q3 2022 Earnings Call Transcript
ARWR earnings call for the period ending June 30, 2022.
United states
Hong kong
Vincent anzalone
Patrick obrien
Keay nakae
Mcneil neurologics
Ted tenthoff piper sandler
Keay nakae chardan
Christopher anzalone
Mayank mamtani
Prakhar agrawal cantor fitzgerald
Prakhar agrawal
Patrick trucchio
James hamilton
Joel beatty baird
Chris anzalone
Spectrum Pharmaceuticals (SPPI) Q1 2022 Earnings Call Transcript
SPPI earnings call for the period ending March 31, 2022.
United kingdom
New york
United states
Francois lebel
Michael grabow
Maury raycroft
Mayank mamtani
Brittany bradrick
Maury raycroft jefferies
Mayank mamtanib riley
Nora brennan
Red white
British columbia cancer center
Hanmi pharmaceuticals
Spectrum pharmaceuticals
Company analyst
Agenus (AGEN) Q1 2022 Earnings Call Transcript
AGEN earnings call for the period ending March 31, 2022.
United states
Jennifer buell
Christine klaskin
Ethan lovell
Mayank mamtanib riley
Dhan chand
Mayank mamtani
Garo armen
Gilead sciences
External affairs
Steveno day
Drug discovery
Nowi d
Chief executive
Chief accounting
vimarsana © 2020. All Rights Reserved.